IMCC - Dividend announcements

TORONTO and GLIL YAM, Israel, Aug. 13, 2025 /PRNewswire/ -- IM Cannabis Corp. ("IM Cannabis" or the "Company") (NASDAQ:IMCC), a leading medical cannabis company with operations in Israel and Germany, announces that it has agreed with holders (each, a "Holder") of common share purchase warrants ("November 2024 Warrants") issued by the Company as part of its non-brokered private placement offering which closed on November 12, 2024 to: (x) reduce the exercise price of each November 2024 Warrant from C$4.32 to C$3.43; and (y) extend the expiration date of each November 2024 Warrant from November 12, 2026 to July 31, 2030 (together, the "Transaction"). Form F-3 Resale Registration Statement The

Highlights: Flowr exported first shipment of premium medical cannabis to Israel for $825,000.The shipment represents the Company's first export into an international market.Holigen in Portugal expects first harvest of indoor grown cannabis in mid-January 2022 with initial in-process testing at more than 29% THC content. TORONTO, Jan. 13, 2022 (GLOBE NEWSWIRE) -- The Flowr Corporation ("Flowr" or the "Company") (TSXV:FLWR, OTC:FLWPF) is pleased to announce that it has completed its first shipment from Canada to Israel, as part of the previously announced international supply agreement (the "Supply Agreement") with Focus Medical Herbs Ltd. ("Focus Medical"), a company which IM Cannabis Cor